Transformation Under Pressure: Discovery of a Novel Crystalline Form of Anthelmintic Drug Praziquantel using High-Pressure Supercritical Carbon Dioxide.

[1]  Azadeh Kermanshahi-pour,et al.  Supercritical Carbon Dioxide for Pharmaceutical Co-Crystal Production , 2020 .

[2]  Hossein Rostamian,et al.  Production and characterization of ultrafine aspirin particles by rapid expansion of supercritical solution with solid co-solvent (RESS-SC): expansion parameters effects , 2020, Particulate Science and Technology.

[3]  B. Perissutti,et al.  Mechanochemical Formation of Racemic Praziquantel Hemihydrate with Improved Biopharmaceutical Properties , 2020, Pharmaceutics.

[4]  M. Kiselev,et al.  Correlation between the conformational crossover of carbamazepine and its polymorphic transition in supercritical CO2: On the way to polymorph control. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  E. Franceschinis,et al.  Exploring mechanochemical parameters using a DoE approach: crystal structure solution from Synchrotron XRPD and characterization of a new praziquantel polymorph. , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  K. Ryan,et al.  From batch to continuous - New opportunities for supercritical CO2 technology in pharmaceutical manufacturing. , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  A. Cabañas,et al.  Polymorphism in the co-crystallization of the anticonvulsant drug carbamazepine and saccharin using supercritical CO2 as an anti-solvent , 2018, The Journal of Supercritical Fluids.

[8]  H. C. de Sousa,et al.  Supercritical carbon dioxide‐based technologies for the production of drug nanoparticles/nanocrystals – A comprehensive review☆ , 2018, Advanced drug delivery reviews.

[9]  B. Perissutti,et al.  Milling and comilling Praziquantel at cryogenic and room temperatures: Assessment of the process‐induced effects on drug properties , 2018, Journal of pharmaceutical and biomedical analysis.

[10]  B. Perissutti,et al.  A new soluble and bioactive polymorph of praziquantel , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  Elisabeth Badens,et al.  Current situation and perspectives in drug formulation by using supercritical fluid technology , 2017 .

[12]  N. Foster,et al.  Scale − Up and economic evaluation of the atomized rapid injection solvent extraction process , 2017 .

[13]  M. Kiselev,et al.  Screening of conformational polymorphism of ibuprofen in supercritical CO 2 , 2017 .

[14]  J. Lovrić,et al.  Biopharmaceutical characterization of praziquantel cocrystals and cyclodextrin complexes prepared by grinding , 2017, Journal of pharmaceutical and biomedical analysis.

[15]  M. Türk,et al.  Polymorphic properties of micronized mefenamic acid, nabumetone, paracetamol and tolbutamide produced by rapid expansion of supercritical solutions (RESS) , 2016 .

[16]  C. I. Sainz-Díaz,et al.  Molecular and crystal structure of praziquantel. Spectroscopic properties and crystal polymorphism. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  M. Caumon,et al.  Evidence of two types of fluid inclusions in single crystals , 2016 .

[18]  B. Pejcic,et al.  Monitoring dissolved carbon dioxide and methane in brine environments at high pressure using IR-ATR spectroscopy , 2016 .

[19]  Eun Hee Lee.  A practical guide to pharmaceutical polymorph screening & selection , 2014 .

[20]  Andreas Braeuer,et al.  Manipulating the size, the morphology and the polymorphism of acetaminophen using supercritical antisolvent (SAS) precipitation , 2013 .

[21]  H. Höpfl,et al.  Cocrystals of Active Pharmaceutical Ingredients—Praziquantel in Combination with Oxalic, Malonic, Succinic, Maleic, Fumaric, Glutaric, Adipic, And Pimelic Acids , 2013 .

[22]  Tudor I. Oprea,et al.  BDDCS Applied to Over 900 Drugs , 2011, The AAPS Journal.

[23]  R. Gobetto,et al.  Didanosine polymorphism in a supercritical antisolvent process. , 2010, Journal of pharmaceutical sciences.

[24]  S. Rohani,et al.  Measurement and Prediction of the Solubility of Stearic Acid Polymorphs by the UNIQUAC Equation , 2008 .

[25]  W. Jiskoot,et al.  Ways of manipulating the polymorphism of glycine during supercritical fluid crystallisation , 2008 .

[26]  K. Moribe,et al.  Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formation. , 2008, Advanced drug delivery reviews.

[27]  R. Lucky,et al.  Study of the RESS Process for Producing Beclomethasone-17,21-Dipropionate Particles Suitable for Pulmonary Delivery , 2008, AAPS PharmSciTech.

[28]  W. Jiskoot,et al.  Selective Production of Polymorphs and Pseudomorphs Using Supercritical Fluid Crystallization from Aqueous Solutions , 2007 .

[29]  Beatrice Perissutti,et al.  Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel. , 2006, International journal of pharmaceutics.

[30]  T. Sako,et al.  Micronization and Polymorphic Conversion of Tolbutamide and Barbital by Rapid Expansion of Supercritical Solutions , 2006, Drug development and industrial pharmacy.

[31]  M. Todd,et al.  Drugs for the control of parasitic diseases: current status and development in schistosomiasis. , 2003, Trends in parasitology.

[32]  T. Oguchi,et al.  Supercritical carbon dioxide treatment as a method for polymorph preparation of deoxycholic acid. , 2003, International journal of pharmaceutics.

[33]  J. Sotelo,et al.  Interaction between Grapefruit Juice and Praziquantel in Humans , 2002, Antimicrobial Agents and Chemotherapy.

[34]  H. Tong,et al.  Characterization of Two Polymorphs of Salmeterol Xinafoate Crystallized From Supercritical Fluids , 2001, Pharmaceutical Research.

[35]  F. Giordano,et al.  Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[36]  P. York,et al.  Polymorph Control of Sulfathiazole in Supercritical CO2 , 2001, Pharmaceutical Research.

[37]  M. Türk.  Manufacture of submicron drug particles with enhanced dissolution behaviour by rapid expansion processes , 2009 .

[38]  S. Rohani,et al.  Polymorphic Behavior and Crystal Habit of an Anti-Viral/HIV Drug: Stavudine , 2006 .

[39]  A. Immirzi,et al.  Prediction of density in organic crystals , 1977 .